[Asia Economy Reporter Geum Bo-ryeong] Jetema announced on the 24th that it has acquired a domestic patent right related to 'culture medium composition.'



Jetema explained, "This medium is free of animal-derived ingredients and major allergens, allowing the botulinum toxin-producing strain to reach its maximum growth in a short time. This induces a reduction in production time and cost in the botulinum toxin production process."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing